Abstract:OBJECTIVE:To evaluate the relationship between the aberrant expression of P16 and the clinic-pathological features in breast cancers.METHODS:In our study, 72 cases of breast cancer were collected and the expressions of P16, HER-2 (human epidermal growth receptor-2), ER (estrogen receptor), PR (progesterone receptor), P53, Ki-67 were measured by immunohistochemistry. The correlations between the P16 and the clinic-pathological features (menstruation, tumor size, histological grade, lymph node metastasis were statistically analyzed.RESULTS:Aberrant expression of P16 was detected in 36.1%(26/72)of breast cancers. Not only was the staining of P16 increased,but also the subcellular localization was changed from nuclear to cytoplasm or whole cell staining. In general, the occasional cell staining (+) usually presented in nuclear, as expression increased, P16 showed mainly in cytoplasm or whole cells (+++) even diffusive staining in extracellular, and the moderate staining was multi-focal both in nuclear and cytoplasm. The expression of P16 was significantly increased in ER negative group compared with ER positive group (78.6% vs. 9.1%,P=0.000). Statistical analysis showed a significant correlation of high Ki-67 index with the group of P16 positive (Z =-0.263, P=0.003). In addition, significant difference was calculated between pre- and post-menopause (55.6% vs. 24.4%, P=0.008)and P16 expressions were also more credited to the poor-differentiated group in histological grading: 11.8% (2/17) for highly differentiated group, 27.6% (8/29) for moderately differentiated group and 61.5% (16/26) for poorly differentiated group, respectively (P=0.002).CONCLUSION:The aberrant expression of P16 in breast cancers correlated closely with loss of estrogen receptor, high proliferation index or high histological grade, predisposed to the patients of pre-menopause, implicating that the aberrant expression of P16 should be a predictor of poor response to endocrine therapy or more aggressive behavior.

[Preliminary Study of P16 Gene Expression in Pituitary Adenomas].

P16 Overexpression in Pituitary Adenomas Studied by Immunohistochemistry and in Situ Hybridization.

In Situ PCR and Immunohistochemical Studies on P16 Gene in Pituitary Adenomas

Detection of P16 and Hst Gene and Cell Proliferative Cycle in Human Pituitary Adenone and Study of Cell Cycle Regulation Mechanism

Significance of Protein Expressions of P16, FGFR-4 and C-Erbb-2 for the Determination of Biological Behaviors of Pituitary Adenomas

Expression of p16 Protein in Periampullary Carcinoma and Its Clinical Implication

[Evaluation of P16(INK4α) Expression in Thinprep Cervical Specimens for the Predication of High-Grade Cervical Intraepithelial Neoplasia].

EXPRESSION OF P16 GENE IN ORAL SQUAMOUS CELL CARCINOMA AND ITS CLINICOPATHOLOGICAL SIGNIFICANCE

Expression of Pituitary Tumor Transforming Gene, Basic Fibroblast Growth Factor and Proliferating Cell Nuclear Antigen in Human Pituitary Adenomas: Correlation with Invasiveness

Pit-1 Mrna And Protein Expression In Human Pituitary Adenomas

The Protein Expressions of PCNA, P53, Nm23-H 1 and Biological Behavior in Pituitary Adenoma

Significance of tumor suppressor gene p16 expression in primary biliary cancer

Relation of Proliferation and Apoptosis Indexes to the Invasiveness of Pituitary Adenomas

Study of Relatonship Between the Expression of P16 Protein and CT Characteristics in Lung Peripheral Adenocarcinoma

[Aberrant Expression and Correlative Analysis of P16 in Breast Cancers].

Expression of P16 in Non-Small Cell Lung Cancer and Its Prognostic Significance: a Meta-Analysis of Published Literatures.

Pathogenesis analysis of pituitary adenoma based on gene expression profiling.

Expression of p16INK4a in human malignant tumors and its clinical significance

Prognostic and Clinicopathological Significance of Downregulated p16 Expression in Patients with Bladder Cancer: A Systematic Review and Meta-Analysis.

[Expression of Multiple Tumor Suppressor Gene P16 and Its Relationship with Prognosis of Gastric Cancer Patients].

Quantitative study on expression of p16 multiple tumor suppressor gene in salivary gland neoplasm